Exploring the Role of Angiopoietins in Retinal Diseases

• This promotional educational event is presented by Genentech
  **This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2021 or its accredited provider.

Break

Welcome & Announcements

• Judy E. Kim, MD

Mechanisms in the Development and Progression of ERM using Advanced Imaging

• David Sarraf, MD

Challenges in Tele-retinal Screening for Diabetic Retinopathy

• Christina Y. Weng, MD, MBA

Using Imaging to Improve Your Uveitis Game

• Yasha S. Modi, MD

An Update on OCT and Imaging in the Home

• Nancy M. Holekamp, MD

Tele-retina in the Management of AMD and Retinal Vascular Diseases

• Sophie J. Bakri, MD

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

Plasmin Kallikrein Inhibition

• Peter K. Kaiser, MD

Discussion

TIE2, Integrin, and VEGF Pathways and Retinal Diseases

• Peter K. Kaiser, MD

Discussion

Biosimilars and Retinal Diseases

• Peter K. Kaiser, MD

Discussion

Gene Therapy for Retinal Vascular Disease

• Peter K. Kaiser, MD

Discussion

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

Complement Inhibition and Dry AMD

• Peter K Kaiser, MD

Discussion

Neuroprotection, Oxidative Stress Reduction, and Toxic Byproduct Accumulation Reduction in Dry AMD

• Peter K Kaiser, MD

Discussion

HTRA1 Inhibition, Inflammasome Regulation, and Other Approaches in Dry AMD

• Peter K Kaiser, MD

Discussion

Tyrosine Kinase Inhibition and Wet AMD

• Peter K Kaiser, MD

Discussion

Break

Lengthening the Treatment Interval in Age-related Macular Degeneration: Current Status and Insights

• This activity is supported by an educational grant from Genentech, a member of the Roche Group

Practical Training in Equipment, Technology, and Insurance

• This session is not approved for CME/CNE/COE Credit(s) and is neither provided by nor endorsed by Hawaiian Eye/Retina 2021 or their accredited provider.

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

• Moderators: Sophie J. Bakri, MD; Caroline R. Baumal, MD

Revelations in Retinal Vein Occlusion Management – What’s New?

• This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Break

Announcements

• Rishi P. Singh, MD

The Role of Fluid in Exudative AMD

• Nancy M. Holekamp, MD

Sustained Delivery of Anti-VEGF Therapy for nAMD

• Carl D. Regillo, MD, FACS

Safety Update on Anti-VEGF Treatment

• Roger A. Goldberg, MD, MBA

Outcomes of Anti-VEGF Treatment for CNV in Fellow Eyes of Previously Treated Patients with Wet AMD

• Tarek S. Hassan, MD

Complement Inhibition for Geographic Atrophy

• Caroline R. Baumal, MD

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

Non-neovascular AMD with Fluid: Exudation vs. Transudation in “Dry” AMD

• David Sarraf, MD

Ang-2 Inhibition for Neovascular AMD

• Caroline R. Baumal, MD

Gene and Cell Therapy Strategies for Neovascular and Atrophic AMD

• Allen C. Ho, MD

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

Panel Discussion

• Moderator: Rishi P. Singh, MD
  Panelists: Caroline R. Baumal, MD; Roger A. Goldberg, MD, MBA; Tarek S. Hassan, MD; Nancy M. Holekamp, MD; Carl D. Regillo, MD, FACS

Break

Diabetic Macular Edema Management in 2021: What’s New?

• This activity is supported by an educational grant from Allergan, Inc.

Practical Training in Equipment, Technology, and Insurance

• This session is not approved for CME/CNE/COE Credit(s) and is neither provided by nor endorsed by Hawaiian Eye/Retina 2021 or their accredited provider.

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

• Moderators: Allen C. Ho, MD; Peter K. Kaiser, MD

Neuromyelitis Optica Spectrum Disorder (NMOSD): Novel Therapeutic Options to Manage a Difficult-to-Diagnose Disorder

• This activity is supported by an educational grant from Genentech, a member of the Roche Group

Moving Diabetic Retinopathy Treatment Forward by Early Intervention to Improve Long-term Outcomes

• This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc.

Break

Announcements

• Michael S. Ip, MD

Classification and Treatment of Macular Telangiectasia: Update on Treatment

• Roger A. Goldberg, MD, MBA

Recognition of PAMM in Retinal Vascular Occlusions: Why Does it Matter?

• David Sarraf, MD

Top 5 Lessons Learned from the SCORE2 Study

• Michael S. Ip, MD

Organization of the Retinal Capillary Plexus and New Predictive Biomarkers in CRVO

• David Sarraf, MD

Diabetic Retinal Neurodegeneration: Should We Redefine Diabetic Retinopathy?

• Elliott H. Sohn, MD

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

A Case-based Review of the Latest DRCR Retina Network Trials

• Christina Y. Weng, MD, MBA

Diabetic Retinopathy Regression: Disease Modification or Just a Pretty Picture

• Roger A. Goldberg, MD, MBA

When to Observe and When to Treat in DME: Applying Lessons from Clinical Trials

• Yasha S. Modi, MD

Ang-2 Inhibition for Diabetic Macular Edema and Diabetic Retinopathy

• Michael S. Ip, MD

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

Introduction

• Michael S. Ip, MD

Debate: Advanced NPDR Should be Treated with Anti-VEGF Therapy

• Yes: Christina Y. Weng, MD, MBA
  No: Roger A. Goldberg, MD, MBA
  Rebuttal: Christina Y. Weng, MD, MBA
  Rebuttal: Roger A. Goldberg, MD, MBA

Panel Discussion: How I am Currently Managing My Retinal Vascular Disease Patients

• Moderator: Michael S. Ip, MD
  Panelists: Roger A. Goldberg, MD, MBA; Yasha S. Modi, MD; David Sarraf, MD; Elliott H. Sohn, MD; Christina Y. Weng, MD, MBA

Break

The Tie2 Pathway: A New Approach in Retinal Disease?

• This activity is supported by an educational grant from Genentech, a member of the Roche Group

Practical Training in Equipment, Technology, and Insurance

• This session is not approved for CME/CNE/COE Credit(s) and is neither provided by nor endorsed by Hawaiian Eye/Retina 2021 or their accredited provider.

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

• Moderators: Debra A. Goldstein, MD; Elliott H. Sohn, MD

Early Identification and Management Strategies for Patients With DME

• Faculty: Nathan M. Radcliffe, MD; Inder Paul Singh, MD
  This promotional educational event is presented by Allergan, an AbbVie Company

• ** This session is not approved for AMA PRA Category 1 Credit(s)™ and is neither provided by nor endorsed by Retina 2021 or its accredited provider.

Break

Announcements

• Caroline R. Baumal, MD

The Aqueous Humor Liquid Biopsy for Retinoblastoma

• Jesse L. Berry, MD

Genetic Testing 101

• Elliott H. Sohn, MD

Rumors about Tumors: Top Do Not Miss Tips from an Ocular Oncologist

• Jesse L. Berry, MD

ROP: Where Are We Today

• Eric D. Nudleman, MD, PhD

Melanoma: Management in 2021

• Jesse L. Berry, MD

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

Subretinal Gene Therapy and Surgical Lessons Learned

• Christina Y. Weng, MD, MBA

Pediatric Surgery What I Have Learned

• Eric D. Nudleman, MD, PhD

What I Have Learned from the COVID-19 Pandemic

• Yasha S. Modi, MD

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

Infectious Retinitis

• Debra A. Goldstein, MD

Anti-VEGF in ROP

• Eric D. Nudleman, MD, PhD

My Favorite Cases of 2020

• Caroline R. Baumal, MD

Break

Therapeutic Targeting of the Complement System in Geography Atrophy

• This activity is supported by an educational grant from Apellis

Extend your learning beyond the meeting room and experience education with a view. Enjoy open dialogue among a small group of peers in a relaxed, outdoor setting.

• Moderators: Carl C. Awh, MD

Educational Program & Breakfast

Break

Announcements

• Carl D. Regillo, MD, FACS

Congenital Optic Nerve Anomalies Surgical Management

• Caroline R. Baumal, MD

Perfluorocarbon Liquids in Retinal Detachment Repair: Pearls and Pitfalls

• Carl D. Regillo, MD, FACS

Management of Challenging Macular Holes: A Conceptual Approach

• Yasha S. Modi, MD

New Innovations in Surgical Sterility

• Tarek S. Hassan, MD

Update on New Surgical Instruments

• Carl C. Awh, MD

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

Interactive Panel: Vitreoretinal Surgical Pearls

• Moderator: Carl D. Regillo, MD, FACS
  Panelists: Carl C. Awh, MD; Tarek S. Hassan, MD; Yasha S. Modi, MD; Christina Y. Weng, MD

REFRESHMENTS & NETWORKING IN THE EXHIBIT HALL

Best Cases of 2020

• Moderator: Judy E. Kim, MD
  Panelists: David Sarraf, MD; Christina Y. Weng, MD, MBA; Roger A. Goldberg, MD, MBA

Meeting Concludes